DATATRAK expands and rebrands unified software suite

DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the expansion and rebranding of their unified software suite as DATATRAK ONE™.  The unified software suite consists of seven products – all of which are being demonstrated at the 2011 DIA National Meeting.

DATATRAK ONE™ provides an end-to-end clinical enterprise solution by empowering clinical users and service providers with the components necessary for efficiently designing, delivering and managing their clinical trials.  Being the only patented, unified solution differentiates DATATRAK in a marketplace where eClinical efficiency is compromised by integration.  The DATATRAK ONE™ unified product suite includes the following products, all built on a single database:

  • uCTMS - unified Clinical Trial Management System
  • uDesign - unified Trial Design
  • uEDC - unified Electronic Data Collection
  • uIRT - unified Interactive Response Technology
  • uSafety - unified Safety Submission
  • uTrain - unified Training Program
  • uCDR - unified Clinical Data Repository

"Because DATATRAK ONE™'s products are unified and work seamlessly together, there is no need to make complex data connections.  Our unique design gives our clients an advantage in the marketplace in terms of cost, timelines and ease-of-use," stated Chris Wilke, DATATRAK's Chief Technology Officer.  "In providing a simple, easy-to-use product suite, the DATATRAK ONE™ solution safely accelerates drug programs from concept to cure™."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Extending the reach of Amperia™: Simplifying his-tagged protein quantification across expression and development workflows